DF
Therapeutic Areas
Precision Motion Health Pipeline
| Drug | Indication | Phase |
|---|---|---|
| EFA-Based Assessment & Intelligence | Musculoskeletal/Soft Tissue Injury Assessment & Recovery | Commercial |
| AI-Predictive Risk Analytics | Musculoskeletal Injury Risk Stratification | Development/Commercialization |
| Tele-EFA Program | Remote Musculoskeletal Assessment | Commercial |
Leadership Team at Precision Motion Health
AZ
Ahmed Zarrugh
Chief Executive Officer
SH
Sheila Harless
Vice President of Operations
DC
Devin Cross
Chief Scientific Officer